Showing results (21-30 of 49) with videos related to
Sort By:
Pageof 5
Journal for Immunotherapy of Cancer|January 27, 2023
SARS-CoV-2 infections in pediatric and young adult recipients of chimeric antigen receptor T-cell therapy: an international registry reportKevin Owen McNerney, Rebecca M Richards, Paibel Aguayo-Hiraldo, et al.Blood|July 1, 2022
KIR-favorable TCR-αβ/CD19-depleted haploidentical HCT in children with ALL/AML/MDS: primary analysis of the PTCTC ONC1401 trialMichael A Pulsipher, Kwang W Ahn, Nancy J Bunin, et al.Bone Marrow Transplantation|February 3, 2022
Significant improvement of child physical and emotional functioning after familial haploidentical stem cell transplantSusan K Parsons, Angie Mae Rodday, Ruth Ann Weidner, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 13, 2017
Allogeneic Hematopoietic Cell Transplantation Using Treosulfan-Based Conditioning for Treatment of Marrow Failure DisordersLauri M Burroughs, Akiko Shimamura, Julie-An Talano, et al.Frontiers in Immunology|December 26, 2022
Donor chimerism and immune reconstitution following haploidentical transplantation in sickle cell diseaseYaya Chu, Julie-An Talano, Lee Ann Baxter-Lowe, et al.Frontiers in Neurology|June 6, 2024
Neurocognitive outcome in children with sickle cell disease after myeloimmunoablative conditioning and haploidentical hematopoietic stem cell transplantation: a non-randomized clinical trialSuzanne Braniecki, Elliott Vichinsky, Mark C Walters, et al.The Journal of Infectious Diseases|December 30, 2022
Manufacture and Characterization of Good Manufacturing Practice-Compliant SARS-COV-2 Cytotoxic T LymphocytesYaya Chu, Jordan Milner, Margaret Lamb, et al.Blood|July 13, 2018
Reduced-intensity conditioning for hematopoietic cell transplant for HLH and primary immune deficienciesCarl E Allen, Rebecca Marsh, Peter Dawson, et al.Blood Advances|July 23, 2024
Effect of rabbit ATG PK on outcomes after TCR-αβ/CD19-depleted pediatric haploidentical HCT for hematologic malignancyChristopher C Dvorak, Janel R Long-Boyle, Lucia Holbrook-Brown, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 9, 2014
Treosulfan-based conditioning and hematopoietic cell transplantation for nonmalignant diseases: a prospective multicenter trialLauri M Burroughs, Eneida R Nemecek, Troy R Torgerson, et al.Pageof 5